Monica Fradkin, RN, MPH, Smilow Cancer Hospital at Yale-New Haven, discusses improving communication between clinical staff and research staff for patients who are approved for clinical trials.
Monica Fradkin, RN, MPH, Smilow Cancer Hospital at Yale-New Haven, discusses improving communication between clinical staff and research staff for patients who are approved for clinical trials.
A cross-organizational communication system was established between the hospital and Yale with the common goal of safely treating patients in clinical trials and providing high-quality research care.
To accomplish this, a number of aspects were established, such as hand-off tools, clinical staff education, and documentation tools in the electronic medical records. Also, there is now better communication between the two institutions, ensuring that any information on new clinical trials is given to the treating nurses whose patients may be eligible.
Survival Benefit, Durable Responses Continue at 3 Years With Liso-cel in Second-line LBCL
July 15th 2024Three-year findings from the TRANSFORM trial provide further evidence that liso-cel should be considered as the new standard of care along with other CAR T-cell therapies for patients with primary refractory or relapsed LBCL, an expert said.